RxDoctor Payments Data

Jana Fox, MD

Therapeutic Radiology · Bronx, NYNPI 1154467363

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $1,500 of the $2,024 with a category attached, or 74.1%. Novocure Inc. accounts for 80.2% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2022 at $1,735 and has fallen 97.7% since, to $40 in 2025.

$2,024in general payments, 2019–2025

Across 13 payments — averaging $155.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novocure Inc.$2K
  • Reflexion Medical, Inc.$191
  • GT Medical Technologies, Inc$143
  • Siemens Medical Solutions USA, Inc.$43
  • Elekta, Inc.$25
$1,850in research payments, 2019–2025

Across 1 payment — averaging $1850.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Merck$2K

What the payments were for

  • Consulting fees$1,50074%
  • Travel & lodging$60%
  • Food & beverage$51926%

General payments by program year

20
21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,024 in reported general payments places this provider in the 75th percentile of 24 therapeutic radiology providers in New York.

See all therapeutic radiology providers in New York

Medicare billing

Part B allowed, 2024
$261,983
Medicare patients
318
Services billed
1,074

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other therapeutic radiology in Bronx

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →